2
40
Growth Score
-2 pts
Heat Score
4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
MII invests in dermatology related technologies across different stages seed to growth.
- Oron Yacoby-Zeevi: Scientific ConsultantPast Role: NeuroSense Therapeutics, Chief Scientific Officer, Director of the Board
- Junichi Hamada: Co-Founder & Managing Director
About the Company
MII invests in dermatology related technologies across different stages seed to growth – covering the pharma, biotech, medical device, digital health, and cosmetic sectors. Through the fund's partnership with Maruho, Japan's preeminent leader in dermatology, the Mii Fund aims to bring Israeli innovation in dermatology and skin care to the
Japanese market, in effect giving Japan first rights to next generation skin therapies.
